Treatment Landscape of Renal Cell Carcinoma
2023 · Current Treatment Options in Oncology · 100 citations
https://doi.org/10.1007/s11864-023-01161-5
Y
Yu‐Wei Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
126
Papers
1.6K
Citations
24
h-index
43
i10-index
Yu‐Wei Chen is an academic researcher from UC San Diego Health System. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Prostate Cancer Diagnosis and Treatment & Renal cell carcinoma treatment. The author has an h-index of 24, co-authored 108 publications.
ORCID: 0000-0001-7988-319XPapers by this author
worksAssociation of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
2021 · Biomarker Research · 41 citations
https://doi.org/10.1186/s40364-021-00334-4
Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting
2019 · Research and Practice in Thrombosis and Haemostasis · 19 citations
https://doi.org/10.1002/rth2.12176
Emerging innovative treatment strategies for advanced clear cell renal cell carcinoma
2024 · The Oncologist · 14 citations
https://doi.org/10.1093/oncolo/oyae276
Severe acute kidney disease is associated with worse kidney outcome among acute kidney injury patients
2022 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-022-09599-7
Transitions of dialysis status and outcomes after the unplanned first dialysis: a nationwide population-based cohort study
2023 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-023-39913-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat